These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Pseudomonas aeruginosa ExoU, a toxin transported by the type III secretion system, kills Saccharomyces cerevisiae. Rabin SD; Hauser AR Infect Immun; 2003 Jul; 71(7):4144-50. PubMed ID: 12819106 [TBL] [Abstract][Full Text] [Related]
28. Effector ExoU from the type III secretion system is an important modulator of gene expression in lung epithelial cells in response to Pseudomonas aeruginosa infection. McMorran B; Town L; Costelloe E; Palmer J; Engel J; Hume D; Wainwright B Infect Immun; 2003 Oct; 71(10):6035-44. PubMed ID: 14500525 [TBL] [Abstract][Full Text] [Related]
29. A live auxotrophic vaccine confers mucosal immunity and protection against lethal pneumonia caused by Pseudomonas aeruginosa. Cabral MP; Correia A; Vilanova M; Gärtner F; Moscoso M; García P; Vallejo JA; Pérez A; Francisco-Tomé M; Fuentes-Valverde V; Bou G PLoS Pathog; 2020 Feb; 16(2):e1008311. PubMed ID: 32040500 [TBL] [Abstract][Full Text] [Related]
31. ExoU-induced vascular hyperpermeability and platelet activation in the course of experimental Pseudomonas aeruginosa pneumosepsis. Machado GB; de Assis MC; Leão R; Saliba AM; Silva MC; Suassuna JH; de Oliveira AV; Plotkowski MC Shock; 2010 Mar; 33(3):315-21. PubMed ID: 19543153 [TBL] [Abstract][Full Text] [Related]
32. Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Hauser AR; Cobb E; Bodi M; Mariscal D; Vallés J; Engel JN; Rello J Crit Care Med; 2002 Mar; 30(3):521-8. PubMed ID: 11990909 [TBL] [Abstract][Full Text] [Related]
33. The alternative activation pathway and complement component C3 are critical for a protective immune response against Pseudomonas aeruginosa in a murine model of pneumonia. Mueller-Ortiz SL; Drouin SM; Wetsel RA Infect Immun; 2004 May; 72(5):2899-906. PubMed ID: 15102802 [TBL] [Abstract][Full Text] [Related]
34. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Finck-Barbançon V; Goranson J; Zhu L; Sawa T; Wiener-Kronish JP; Fleiszig SM; Wu C; Mende-Mueller L; Frank DW Mol Microbiol; 1997 Aug; 25(3):547-57. PubMed ID: 9302017 [TBL] [Abstract][Full Text] [Related]
35. Phosphatidylinositol 4,5-Bisphosphate-Dependent Oligomerization of the Pseudomonas aeruginosa Cytotoxin ExoU. Zhang A; Veesenmeyer JL; Hauser AR Infect Immun; 2018 Jan; 86(1):. PubMed ID: 28993456 [TBL] [Abstract][Full Text] [Related]
36. Pseudomonas aeruginosa cystic fibrosis isolates induce rapid, type III secretion-dependent, but ExoU-independent, oncosis of macrophages and polymorphonuclear neutrophils. Dacheux D; Toussaint B; Richard M; Brochier G; Croize J; Attree I Infect Immun; 2000 May; 68(5):2916-24. PubMed ID: 10768989 [TBL] [Abstract][Full Text] [Related]
37. Lysophospholipase A activity of Pseudomonas aeruginosa type III secretory toxin ExoU. Tamura M; Ajayi T; Allmond LR; Moriyama K; Wiener-Kronish JP; Sawa T Biochem Biophys Res Commun; 2004 Apr; 316(2):323-31. PubMed ID: 15020221 [TBL] [Abstract][Full Text] [Related]
38. Comparison of type III secretion system virulence among fluoroquinolone-susceptible and -resistant clinical isolates of Pseudomonas aeruginosa. Wong-Beringer A; Wiener-Kronish J; Lynch S; Flanagan J Clin Microbiol Infect; 2008 Apr; 14(4):330-6. PubMed ID: 18190571 [TBL] [Abstract][Full Text] [Related]
39. Development of loop-mediated isothermal amplification assays for genotyping of Type III Secretion System in Pseudomonas aeruginosa. Shi H; Chen Z; Kan J Lett Appl Microbiol; 2015 Oct; 61(4):361-6. PubMed ID: 26219625 [TBL] [Abstract][Full Text] [Related]
40. IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense. Steinhauser ML; Hogaboam CM; Kunkel SL; Lukacs NW; Strieter RM; Standiford TJ J Immunol; 1999 Jan; 162(1):392-9. PubMed ID: 9886412 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]